Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.


OBJECTIVES Atomoxetine is commonly used to treat attention-deficit hyperactivity disorder (ADHD) in children with a broad range of cognitive abilities. We examined the association between level of cognitive functioning as determined by IQ and clinical response during treatment with atomoxetine. METHODS The records of all the children and adolescents… (More)
DOI: 10.2165/11590450-000000000-00000


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics